The importance of age in allocating health care resources: Does intervention-type matter?

Health Economics

Volumn 14, Issue 7, 2005, Pages 669-678

  Johri, Mira ^a,b,c   Damschroder, Laura J ^d,e   Zikmund Fisher, Brian J ^d,e   Ubel, Peter A ^d,e,f  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Prog Improving Hlth Care Decisions   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Age factors; Equity; Health care rationing; Health priorities; QALY

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANALGESIA; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEPRESSION; EMERGENCY MEDICINE; FEMALE; HEALTH CARE; HEALTH PROGRAM; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PALLIATIVE THERAPY; PLASTIC SURGERY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY ADJUSTED LIFE YEAR; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RESOURCE ALLOCATION; SOCIAL BELIEF; STATISTICAL SIGNIFICANCE;

ADULT; AGE FACTORS; AGED; ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE RATIONING; HEALTH CARE SURVEYS; HEALTH PRIORITIES; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS;

EID: 21844477310     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.958     Document Type: Article

References (30)

1. Avorn J. Benefit and cost analysis in geriatric care. Turning age discrimination into health policy. New Engl J Med 1984; 310: 1294-1301.
2. Harris J. QALYfying the value of life. J Med Ethics 1987; 13: 117-123.
3. Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ 1997; 16: 1-31.
4. Donaldson C, Atkinson A, Bond J, Wright K. Should QALYs be programme-specific? J Health Econ 1988; 7: 239-257.
5. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine (1st edn). Oxford University Press: Oxford, 1996.
6. Welch HG. Comparing apples and oranges: does cost-effectiveness analysis deal fairly with the old and young? Gerontologist 1991; 31: 332-336.
7. Johannesson M. The impact of age on the cost-effectiveness of hypertension treatment: an analysis of randomized drug trials. Med Decision Making 1994; 14: 236-244.
8. Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 1997; 16: 33-64.
9. Johannesson M, Meltzer D, O'Conor RM. Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertension. Med Decision Making 1997; 17: 382-389.
10. Lewis PA, Charny M. Which of two individuals do you treat when only their ages are different and you can't treat both? J Med Ethics 1989; 15: 28-34.
11. Nord E, Richardson J, Street A, Kuhse H, Singer P. Maximizing health benefits vs egalitarianism: an Australian survey of health issues. Social Sci Med 1995; 41: 1429-1437.
12. Busschbach JJ, Hessing DJ, de Charro FT. The utility of health at different stages in life: a quantitative approach. Social Sci Med 1993; 37: 153-158.
13. Cropper ML, Ayede SK, Portney PR. Preferences for life-saving programs: how the public discounts time and age. J Risk Uncertainty 1994; 243-265.
14. Johannesson M, Johansson PO. Is the valuation of a QALY gained independent of age? Some empirical evidence. J Health Econ 1997; 16: 589-599.
15. Rodriguez E, Pinto JL. The social value of health programmes: is age a relevant factor? Health Econ 2000; 9: 611-621.
16. Ratcliffe J. Public preferences for the allocation of donor liver grafts for transplantation. Health Econ 2000; 9: 137-148.
17. Tsuchiya A, Dolan P, Shaw R. Measuring people's preferences regarding ageism in health: some methodological issues and some fresh evidence. Social Sci Med 2003; 57: 687-696.
18. Williams A. Intergenerational equity: an exploration of the 'fair innings' argument. Health Econ 1997; 6: 117-132.
19. Menzel P, Gold MR, Nord E, Pinto-Prades JL, Richardson J, Ubel P. Toward a broader view of values in cost-effectiveness analysis of health. Hastings Center Rep 1999; 29: 7-15.
20. Nord E, Pinto JL, Richardson J, Menzel P, Ubel P. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ 1999; 8: 25-39.
21. Murray CJ, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard University Press: Cambridge, 1996.
22. Nord E, Street A, Richardson J, Kuhse H, Singer P. The significance of age and duration of effect in social evaluation of health care. Health Care Anal 1996; 4: 103-111.
23. Charny MC, Lewis PA, Farrow SC. Choosing who shall not be treated in the NHS. Social Sci Med 1989; 28: 1331-1338.
24. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
25. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrika 1986; 42: 121-130.
26. Horton NJ, Lipsitz SR. Review of software to fit generalized estimating equation regression models. Am Stat 1999; 53: 160-169.
27. Tsuchiya A. Age-related preferences and age weighting health benefits. Social Sci Med 1999; 48: 267-276.
28. Choudhry N, Slaughter P, Sykora K, Naylor CD. Distributional dilemmas in health policy: large benefits for a few or smaller benefits for many? J Health Serv Res Policy 1997; 2: 212-216.
29. Shiell A, Hawe P, Seymour J. Values and preferences are not necessarily the same. Health Econ 1997; 6: 515-518.
30. Johri M, Ubel PA. Setting organ allocation priorities: should we care what the public cares about? Liver Transplant 2003; 9: 878-880.